Document ID: chunk:federal_register_of_legislation:F2024L01521:clause:1_20
Version: federal_register_of_legislation:F2024L01521
Segment Type: clause
Provision Reference: sch 1 cl 20
Character Range: 10606–11495

20  Schedule 1 (table)
After:
Hypromellose with carbomer 980  Ocular lubricating gel 3 mg-2 mg per g, 10 g  Application to the Eye  HPMC PAA  between 1 October 2024 and 30 June 2025—0 months stock by reference to usual demand

insert:
Imatinib  Capsule 100 mg (as mesilate)  Oral  ARX-IMATINIB     3 months stock by reference to usual demand of both Imatinib-APOTEX and ARX-IMATINIB added together
Imatinib  Capsule 100 mg (as mesilate)  Oral  Imatinib-APOTEX  3 months stock by reference to usual demand of both Imatinib-APOTEX and ARX-IMATINIB added together
Imatinib  Capsule 400 mg (as mesilate)  Oral  ARX-IMATINIB     3 months stock by reference to usual demand of both Imatinib-APOTEX and ARX-IMATINIB added together
Imatinib  Capsule 400 mg (as mesilate)  Oral  Imatinib-APOTEX  3 months stock by reference to usual demand of both Imatinib-APOTEX and ARX-IMATINIB added together